Blue March: Raising Awareness for Colorectal Cancer
Each March, the “Blue March” campaign aims to increase public awareness of the importance of colorectal cancer screening and prevention. This initiative highlights the impact of early detection and encourages individuals to take proactive steps towards maintaining their health.
Understanding Colorectal Cancer
Colorectal cancer is the second most common cancer diagnosed in women and the third most common in men in France. It affects more than 47,000 people annually in the country [Ligue contre le cancer]. The cancer often develops from benign tumors, known as adenomatous polyps. Detecting and removing these polyps can significantly reduce, or even eliminate, the risk of cancer development [Ligue contre le cancer].
The Importance of Early Detection
Early diagnosis is crucial for successful treatment. In 90% of cases, colorectal cancer is curable when detected at an early stage, thanks to immunological testing [Ligue contre le cancer] and [Paris.fr]. However, if diagnosis is delayed, nearly half of patients succumb to the disease [Ligue contre le cancer]. Colorectal cancer is responsible for over 2,200 deaths each year in the Île-de-France region alone [Paris.fr].
Prevention and Risk Reduction
Lifestyle factors can play a role in reducing the risk of colorectal cancer. Engaging in 30 minutes of physical activity daily can decrease the risk by up to 20% [Ligue contre le cancer].
The 2026 Campaign: A Shocking Approach
The 2026 campaign utilizes a provocative slogan, “Va chier!” (Travel shit!), to break down taboos and encourage individuals aged 50-74 to undergo screening [Ligue Cancer 44]. The campaign features support from public figures, including Anthony Authie, Franck Dubosc, Kyan Khojandi, Enzo Lefort, Marine Leonardi, Paola Locatelli, Mademoiselle Agnès, and Suzane [Ligue contre le cancer].
Supporting the Cause
The Ligue contre le cancer offers a solidarity shop where purchasing items like t-shirts, tote bags, and mugs contributes to the fight against colorectal cancer [Ligue contre le cancer].
The Role of Research
The Fondation de l’Avenir has supported medical research on colorectal cancer for over 20 years, focusing on diagnosis, treatment, and improving the quality of life for patients [Fondation de l’Avenir]. When detected early, the five-year survival rate exceeds 90%, but drops to 11% at an advanced stage with metastases [Fondation de l’Avenir].
A simple screening test is recommended every two years for individuals starting at age 50 [Fondation de l’Avenir].